How to read: Every bubble is one Indian pemetrexed exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Pemetrexed report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial pemetrexed trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian pemetrexed suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Pemetrexed India trade report
P
Product scope
Pemetrexed
All variants merged — branded and generic formulations of pemetrexed
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
110
Every commercial pemetrexed trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a steady rise: Oct $9.6K, Nov $460.2K, Dec $505.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$9.6K
Oct USD
10 shipments
2
$460.2K
Nov USD
+4709.8% MoM
3
$505.9K
Dec USD
+9.9% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 4709.8% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $10K, making it the weakest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: FRESENIUS KABI ONCOLOGY LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import pemetrexed from India, how much they buy, and who supplies each market
KEY TAKEAWAYGermany absorbs 60.2% of India’s 2025-Q4 pemetrexed trade ($586.9K). Beyond the top 10 destinations, 33 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 33 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much pemetrexed India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$87K
8.9% of trade
11 countries · 43 shipments
Europe
$854K
87.5% of trade
5 countries · 34 shipments
Americas
$22K
2.3% of trade
6 countries · 8 shipments
Africa
$12K
1.2% of trade
11 countries · 25 shipments
Fig 4.1 Germany is the #1 corridor ($587K) — 30 flow arcs from India radiate across 4 continents.
How to read: The world map shows every country colored by how much Indian pemetrexed it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Germany
$587K
21
FRESENIUS KABI ONCOLOGY LTD
$587K
—
—
—
—
2
Poland
$232K
3
RELIANCE LIFE SCIENCES PVT LTD
$232K
—
—
—
—
3
Syria
$40K
2
KHANDELWAL LABORATORIES PVT LTD
$40K
—
—
—
—
4
Nepal
$31K
9
NEON LABORATORIES LTD
$14K
RELIANCE LIFE SCIENCES PVT LTD
$8K
GETWELL PHARMA INDIA PVT LTD
$5K
5
Hungary
$18K
7
FRESENIUS KABI ONCOLOGY LTD
$18K
—
—
—
—
6
Colombia
$17K
1
VENUS REMEDIES LTD
$17K
—
—
—
—
7
Belgium
$9K
2
SUN PHARMACEUTICAL INDUSTRIES LTD
$9K
—
—
—
—
8
Russia
$8K
1
RUS MED EXPORTS PVT LTD
$8K
—
—
—
—
9
Sri Lanka
$7K
4
PLEASANT EXPORTS
$4K
GETWELL PHARMA INDIA PVT LTD
$3K
—
—
10
Afghanistan
$5K
2
RESCUERS LIFE SCIENCES LTD
$5K
—
—
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 8.9% of USD — but Germany is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
60.2%
#1 country share
Germany alone
93.0%
Top 5 share
5 of 33 countries
99.3%
Top 15 share
Long tail of 18 countries = 0.7%
HHI 4220
Destination HHI
Highly concentrated
33
Countries served
Global pharma reach from India
11
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
39 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYFRESENIUS KABI ONCOLOGY LTD ($605.7K, 62.1% share) and RELIANCE LIFE SCIENCES PVT LTD ($243.5K) together control 87.0% of India’s 2025-Q4 pemetrexed trade. The top 5 suppliers hold 94.3%. 39 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian pemetrexed suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 FRESENIUS KABI ONCOLOGY LTD leads by $362K over RELIANCE LIFE SCIENCES PVT LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MC PHARMA DISTRIBUTORS is #19 by value but #2 by volume.
Fig 5.2 FRESENIUS KABI ONCOLOGY LTD also leads by shipment count (30) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MC PHARMA DISTRIBUTORS moves from #2 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 39 pemetrexed suppliers split into strategic segments
KEY TAKEAWAY10 suppliers (25%) generate 98.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 FRESENIUS KABI ONCOLOGY LTD and RELIANCE LIFE SCIENCES PVT LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.3% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
33 importers across 33 countries — who is buying Indian pemetrexed and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 85.0% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian pemetrexed. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 FRESENIUS KABI DEUTSCHLAND GMBH is the #1 importer at $572K (58.7%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian pemetrexed prices vary by supplier, country and dosage form
KEY TAKEAWAYPemetrexed prices span 25093× ($0.012 → $300.52). The coefficient of variation is 1.76. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. RELIANCE LIFE SCIENCESSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. FRESENIUS KABI ONCOLOGYSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. INTAS PHARMACEUTICALS LTDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. RUS MED EXPORTSSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
PLEASANT EXPORTS
Sri Lanka
Injection
5
$2K
$304.74
Sterile formulation premium
Dec 2025
PLEASANT EXPORTS
Sri Lanka
Injection
5
$2K
$300.52
Sterile formulation premium
Dec 2025
UNITED BIOTECH P…
Nepal
Injection
30
$3K
$87.38
Sterile formulation premium
Dec 2025
PLEASANT EXPORTS
Sri Lanka
Injection
10
$605.01
$60.50
Sterile formulation premium
Dec 2025
UNITED BIOTECH P…
Senegal
Injection
60
$3K
$57.25
Sterile formulation premium
Nov 2025
ASPIDA LIFE SCIE…
Kenya
Injection
50
$2K
$44.85
Sterile formulation premium
Dec 2025
GLOBYZ BIOPHARMA…
United States
Injection
6
$235.16
$39.19
Sterile formulation premium
Dec 2025
GLOBYZ BIOPHARMA…
United States
Injection
6
$235.16
$39.19
Sterile formulation premium
Dec 2025
GETWELL PHARMA I…
Sri Lanka
Injection
100
$3K
$31.23
Sterile formulation premium
Nov 2025
PHARMEDA HEALTHC…
Togo
Injection
5
$155.85
$31.17
Sterile formulation premium
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
MC PHARMA DISTRI…
Maldives
Injection
180
$0.388
$0.0022
Sterile formulation premium
Dec 2025
BETA DRUGS LTD
Egypt
Injection
8K
$94.97
$0.012
Sterile formulation premium
Dec 2025
FRESENIUS KABI O…
Germany
Injection
1K
$50.46
$0.042
Sterile formulation premium
Dec 2025
INTAS PHARMACEUT…
DR Congo
Tablet
35K
$2K
$0.056
Dec 2025
DISTINCT IMPEX P…
Jamaica
Injection
15
$1.37
$0.091
Sterile formulation premium
Dec 2025
AMN LIFE SCIENCE…
Myanmar
Injection
299
$50.60
$0.169
Sterile formulation premium
Dec 2025
VENUS REMEDIES LTD
Myanmar
Powder
400
$77.25
$0.193
Small sample / trial shipment
Dec 2025
SANSKRUTI PHARMA
Burkina Faso
Injection
12
$3.60
$0.300
Sterile formulation premium
Dec 2025
GETWELL PHARMA I…
Mauritius
Injection
50
$17.95
$0.359
Sterile formulation premium
Dec 2025
STALLION LABORAT…
Philippines
Powder for Injection
900
$376.71
$0.419
Sterile formulation premium
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship pemetrexed, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYPemetrexed leaves India through 11+ ports. The top 5 (BADDI ICD, MUMBAI AIR (SAHAR), DELHI AIR) handle 99.2% of total USD. ICD moves 15% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 BADDI ICD handles $558K — top 11 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYICD dominates at 15% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$558K
57.2% of USD · 15.5% of ships
AIR
$393K
40.3% of USD · 77.3% of ships
ROAD
$21K
2.2% of USD · 3.6% of ships
SEA
$3K
0.3% of USD · 3.6% of ships
Fig 8.3 The dominant corridor is BADDI ICD → Sea → Europe ($558K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYGermany is the most concentrated destination (HHI 10000, 1 suppliers). Nepal is the most competitive (HHI 3062).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Germany (HHI 10,000) is the most concentrated — Nepal (HHI 3,062) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
FRESENIUS KABI DEUTS…
Germany
FRESENIUS KABI O…
$572K
19
CRITICAL
PII "OST-WEST EXPRESS
Poland
RELIANCE LIFE SC…
$116K
1
HIGH
KUSAIBATY & AL SHIKHA
Syria
KHANDELWAL LABOR…
$40K
2
MEDIUM
A.SAS
Colombia
VENUS REMEDIES LTD
$17K
1
MEDIUM
EUROFINS BIOPHARMA P…
Hungary
FRESENIUS KABI O…
$16K
5
MEDIUM
YETICHEM DISTRIBUTOR…
Nepal
NEON LABORATORIE…
$14K
2
MEDIUM
RUS MED EXPORTS FZE
Russia
RUS MED EXPORTS …
$8K
1
MEDIUM
PHARMACHEM PVT LTD
Nepal
RELIANCE LIFE SC…
$8K
2
MEDIUM
Conclusion: 31 buyers depend on exactly one Indian supplier, representing $830K in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Germany
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Poland
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Syria
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Hungary
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Colombia
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Belgium
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Russia
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Afghanistan
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Senegal
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Dominican Republic
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Singapore
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
DR Congo
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Germany
This Q
HIGH
A2
Offer alternative to top multi-source buyer
This Q
HIGH
A3
Audit Germany lock-ins (HHI 10000)
This Q
MED
A5
Enter Germany (1 suppliers)
This Q
HIGH
A6
Enter Poland (1 suppliers)
This Q
MED
A8
Build Poland distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for Germany tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Germany
Other
1
$587K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
2
Poland
Other
1
$232K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Syria
Other
1
$40K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
Nepal
Asia
4
$31K
0%
LOW
Low competition (4 suppliers), accessible market
5
Hungary
Other
1
$18K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Colombia
Other
1
$17K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Belgium
Other
1
$9K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Russia
Other
1
$8K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Sri Lanka
Asia
2
$7K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
Afghanistan
Asia
1
$5K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Senegal
Africa
1
$4K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Dominican Republic
Other
1
$4K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Kenya
Africa
5
$4K
0%
LOW
Low competition (5 suppliers), accessible market
14
Singapore
Asia
3
$2K
-100%
LOW
Low competition (3 suppliers), accessible market
15
DR Congo
Africa
1
$2K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 110 2025-Q4 Pemetrexed shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/pemetrexed
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 110 2025-Q4 pemetrexed shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian pemetrexed shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
110
across all regions
TOTAL USD
$976K
2025-Q4 FOB value
UNITS
120.3K
tablets, capsules, etc.
SUPPLIERS
39
Indian exporters
BUYERS
33
global importers
COUNTRIES
33
destinations
§10.2 Regional breakdown
Africa
$12K
1.2%
11 ctry · 25 ships
Asia
$87K
8.9%
11 ctry · 43 ships
Europe
$854K
87.5%
5 ctry · 34 ships
Americas
$22K
2.3%
6 ctry · 8 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $12K (1.2%), spanning 11 countries.
🏢
39 Indian suppliers shipped to 33 buyers across 33 countries — average shipment value $9K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 31 global pemetrexed importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian pemetrexed in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
FRESENIUS KABI DEUTSCHLAND GMBH
Germany
19
$572K
FRESENIUS KABI ONCOL…
Injection
2
PII "OST-WEST EXPRESS
Poland
1
$116K
RELIANCE LIFE SCIENC…
Vial
3
KUSAIBATY & AL SHIKHA
Syria
2
$40K
KHANDELWAL LABORATOR…
Injection
4
A.SAS
Colombia
1
$17K
VENUS REMEDIES LTD
lyophilized
5
EUROFINS BIOPHARMA PRODUCT TESTING
Hungary
5
$16K
FRESENIUS KABI ONCOL…
Injection
6
YETICHEM DISTRIBUTORS PVT LTD
Nepal
2
$14K
NEON LABORATORIES LTD
Injection
7
RUS MED EXPORTS FZE
Russia
1
$8K
RUS MED EXPORTS PVT …
Tablet
8
PHARMACHEM PVT LTD
Nepal
2
$8K
RELIANCE LIFE SCIENC…
Injection
9
VISION CARE INTERNATIONAL PVT LTD
Nepal
2
$5K
GETWELL PHARMA INDIA…
Injection
10
NIKHIL PHARMA PVT LTD
Nepal
3
$5K
UNITED BIOTECH PVT LTD
Injection
11
ETEMED MOSLEH LTD
Afghanistan
2
$5K
RESCUERS LIFE SCIENC…
Injection
12
THE ORDER
Senegal
2
$4K
UNITED BIOTECH PVT LTD
Injection
13
YUSEN LOGISTICS BENELUX BELGIUM
Belgium
1
$4K
SUN PHARMACEUTICAL I…
Injection
14
SEAN DOMINICAN SRL
Dominican Republic
1
$4K
RELIANCE LIFE SCIENC…
Tablet
15
THE ESSES PHARMACY (PVT) LTD
Sri Lanka
3
$4K
PLEASANT EXPORTS
Injection
16
THE ESSES PHARMACY (PRIVATE)
Sri Lanka
1
$3K
GETWELL PHARMA INDIA…
Injection
17
GOLD TREE PHARMACEUTICALS LTD
Kenya
1
$2K
ASPIDA LIFE SCIENCES…
Injection
18
RADEEP SERVICES
Singapore
1
$987.26
PHARMA CHOICE LLP
Tablet
19
STATE TRADING ORGANIZATION PLC
Maldives
8
$594.31
MC PHARMA DISTRIBUTORS
Injection
20
N L N
Myanmar
2
$395.35
VENUS REMEDIES LTD
Powder
21
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM
China
1
$390.96
JMB PHARMACEUTICALS …
Injection
22
JOAN DAVIS
Jamaica
1
$375.00
SHARVIK IMPEX (INDIA…
Injection
23
ATLAS TRADING COMPANY
Iraq
2
$325.37
VATS INDUSTRIES PVT …
24
FRESENIUS KABI (SINGAPORE) PTE LTD
Singapore
1
$305.37
FRESENIUS KABI ONCOL…
Injection
25
PSG EXPRESS LINK LTD
Ghana
1
$199.77
PREMIER ENTERPRISE
Injection
26
ABU AHMED
Kenya
1
$151.03
AMARI TRADE ALLIANCE…
Injection
27
ALRAWAN FOR IMPORT AND EXPORT
Egypt
1
$94.97
BETA DRUGS LTD
Injection
28
AORTA COMPANY LTD
Myanmar
1
$50.60
AMN LIFE SCIENCE PVT…
Injection
29
THE MAURITIUS PHARMACY (SEEGOBIN)
Mauritius
1
$17.95
GETWELL PHARMA INDIA…
Injection
30
INDIRA GANDHI MEMOROAL HOSPITAL
Maldives
1
$11.04
NU HOSPITALS PVT LTD
Injection
31
HEALTH CITY CAYMAN ISLANDS (HCCI)
Cayman Islands
1
$0.607
NARAYANA HRUDAYALAYA…
Injection
This report covers 110 2025-Q4 Pemetrexed shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/pemetrexed
Talk to our trade analyst
Need a custom pemetrexed report or a deeper dive into any market? Our team is ready.